Latest Alzheimer’s drug shown less effective in females than males

Published: 18 March 2025

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...

January is Alzheimer’s Awareness Month in Canada

17 Jan 2025

To mark this month, the Neuro-Patient Resource Centre has developed a reading list on Alzheimer’s disease available in their collection. 

Management of Disease Modifying Interventions in Alzheimer's

Tuesday, December 3, 2024 13:00to16:30

This workshop is organized by Dr. Pedro Rosa-Neto, MD, PhD, from The Douglas Research Centre, McGill University, and The Neuro.3801 rue University, Montreal, QC, H3A 2B4, CA/neuroCategory: Academic...

Research on new stem cell models receives $2.6 million

Published: 16 October 2024

Thomas Durcan’s project will dissect the role of microglia in degenerative conditions, to identify new therapeutic strategies for Alzheimer's treatment...

The next phase of Alzheimer treatments

22 Oct 2024

A new trial underway at the Clinical Research Unit is aiming to take Alzheimer's treatment options one step further.

A new chapter in Alzheimer’s research

27 Feb 2023

Innovative clinical research is turning towards complementary treatments to better manage dementia.

Major funding for eye-tracking app to diagnose and support neurological patients

2 Feb 2021

This mobile application will improve the quality of life and care of patients with neurological problems or neurodegenerative disorders.

The onset of Alzheimer’s disease: the importance of family history

Published: 26 February 2018

You’re about to turn 60, and you’re fretting. Your mother has had Alzheimer’s disease since the age of 65. At what age will the disease strike you? A Canadian study published in JAMA Neurology...

Pathway of Alzheimer’s degeneration discovered

Published: 4 July 2018

Finding is key for future treatment and earlier diagnosis ...

Pages

The Neuro logo McGill logoMcGill University Health Centre logoKillam Laureates

 

The Neuro (Montreal Neurological Institute-Hospital) is a bilingual academic healthcare institution. We are a McGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the McGill University Health Centre. We are proud to be a Killam Institution, supported by the Killam Trusts.

 

 

Facebook instagram blue sky iconx, formerly known as twitter linkedIn youtube

Back to top